Back to Gastroenterology
Gastroenterologyv2018Evidence-Based

Tokyo Guidelines 2018 for Acute Cholecystitis

Provides diagnostic criteria and severity grading for acute cholecystitis according to TG18 (Tokyo Guidelines 2018).

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
tokyo guidelines result
—Points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Tokyo Guidelines 2018 for Acute Cholecystitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Diagnostic: ≥1 item from Part A + ≥1 item from Part B (suspected) or Part A + Part B + Part C (definite). Severity: Grade III if any organ dysfunction, Grade II if any moderate criteria, Grade I if neither.

Clinical Pearls & Practice Notes

  • TG18 diagnostic criteria remain unchanged from TG13
  • Suspected diagnosis: Part A + Part B
  • Definite diagnosis: Part A + Part B + Part C
  • Grade III criteria supersede Grade II criteria
  • Early laparoscopic cholecystectomy is recommended for all grades if patient can tolerate surgery

Evidence & Literature Citations

  1. Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41-54. doi: 10.1002/jhbp.515.
  2. Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gomi H, Yoshida M, et al. TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):1-7. doi: 10.1007/s00534-012-0566-y.
  3. Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16. doi: 10.1002/jhbp.518.

Score Interpretation Ranges

Not Acute Cholecystitis≤ pts

Entry criteria not met

Suspected Acute Cholecystitis≤ pts

Suspected diagnosis

Definite Acute Cholecystitis≤ pts

Definite diagnosis

Grade I (Mild)≤ pts

Mild acute cholecystitis

Grade II (Moderate)≤ pts

Moderate acute cholecystitis

Grade III (Severe)≤ pts

Severe acute cholecystitis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.